A comprehensive strategy for quality evaluation of Wushe Zhiyang Pills by integrating UPLC-DAD fingerprint and multi-ingredients rapid quantitation with UPLC-MS/MS technology.
J Pharm Biomed Anal
; 210: 114556, 2022 Feb 20.
Article
in En
| MEDLINE
| ID: mdl-34979493
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drugs, Chinese Herbal
/
Tandem Mass Spectrometry
Type of study:
Prognostic_studies
Language:
En
Journal:
J Pharm Biomed Anal
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom